Phase 2 Refractory Cancer trials recruiting now

All Refractory Cancer trials, every phase

Other phases for Refractory Cancer

Phase 2 Refractory Cancer trials

• A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
  NCT05669430 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 13 locations
• ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
  NCT03686124 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 21 locations
• Fatty Acid Synthase Inhibition in Castration Refractory Prostate Cancer
  NCT04337580 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 2 locations
• Leflunomide or Combination of MEK Inhibitor and Hydroxychloroquine for Refractory Patients With RAS Mutations
  NCT06229340 · Phase: Phase 2 · Ages: 18 Years to 85 Years · Sex: All (male and female) · 1 location

Common questions

What does Phase 2 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.